Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Gallium

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 21,754Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    ARTMS Announces Health Canada Submission for Ga-68 Production & Collaboration
    ARTMS Announces Health Canada Submission for Ga-68 Production & Collaboration

    14 Oct 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20211014005233/en

    BUSINESSWIRE
    14 Oct 2021
    Share Share
    Japanese Prostate Cancer Imaging Study Completes Enrolment
    Japanese Prostate Cancer Imaging Study Completes Enrolment

    08 Sep 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/09/08/2293884/0/en/Japanese-Prostate-Cancer-Imaging-Study-Completes-Enrolment.html

    GLOBENEWSWIRE
    08 Sep 2021
    Share Share
    Telix Pharmaceuticals and GE Healthcare: Maximising 68Ga Supply
    Telix Pharmaceuticals and GE Healthcare: Maximising 68Ga Supply

    13 Oct 2019

    // BIOSPACE

    https://www.biospace.com/article/releases/telix-pharmaceuticals-and-ge-healthcare-maximising-68ga-supply-for-prostate-cancer-imaging/?s=95

    BIOSPACE
    13 Oct 2019
    Share Share
    Roche announces positive results from Gazyva/Gazyvaro phase 3 study
    Roche announces positive results from Gazyva/Gazyvaro phase 3 study

    05 Dec 2016

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=99063&sid=2

    PHARMABIZ
    05 Dec 2016
    Share Share